Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Quest Diagnostics Incorporated (DGX : NYSE)

• Company Description    Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence. Number of Employees: 56,000

• Price / Volume Information    Yesterday's Closing Price: $173.53 Daily Weekly Monthly 20 Day Moving Average: 801,268 shares Shares Outstanding: 111.24 (millions) Market Capitalization: $19,303.89 (millions) Beta: 0.64 52 Week High: $197.55 52 Week Low: $148.70 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -5.78% -5.62% 12 Week -4.36% -5.90% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 500 PLAZA DRIVE - SECAUCUS,NJ 07094 USA ph: 973-520-2700 fax: 201-462-4169 investor@questdiagnostics.com http://www.questdiagnostics.com

• General Corporate Information    Officers James E. Davis - Chairman; Chief Executive Officer and President; Sam A. Samad - Executive Vice President and Chief Financial Offic Michael J. Deppe - Senior Vice President; Corporate Controller and Ch Robert B. Carter - Director Tracey C. Doi Director - Director Peer Information Quest Diagnostics Incorporated (CMTI) Quest Diagnostics Incorporated (CMWLQ) Quest Diagnostics Incorporated (AHG.) Quest Diagnostics Incorporated (ROIX) Quest Diagnostics Incorporated (M.DCE) Quest Diagnostics Incorporated (DHSM) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-OUTP/HM CRE Sector: Medical CUSIP: 74834L100 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 01/29/26 Share - Related Items Shares Outstanding: 111.24 Most Recent Split Date: 6.00 (2.00:1) Beta: 0.64 Market Capitalization: $19,303.89 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 1.84% Current Fiscal Quarter EPS Consensus Estimate: $2.35 Indicated Annual Dividend: $3.20 Current Fiscal Year EPS Consensus Estimate: $10.37 Payout Ratio: 0.33 Number of Estimates in the Fiscal Year Consensus: 9.00 Change In Payout Ratio: 0.06 Estmated Long-Term EPS Growth Rate: 7.58% Last Dividend Paid: 10/03/2025 - $0.80 Next EPS Report Date: 01/29/26

• Fundamental Ratios P/E Current FY Estimate: 16.74 Trailing 12 Months: 17.96 PEG Ratio: 2.21 Price Ratios Price/Book: 2.65 Price/Cash Flow: 12.85 Price / Sales: 1.78 EPS Growth vs. Year Ago Period: 13.04% vs. Previous Quarter: -0.76% Sales Growth vs. Year Ago Period: 13.18% vs. Previous Quarter: 1.99% ROE 12/31/25 - - 09/30/25 - 15.47 06/30/25 - 15.24 ROA 12/31/25 - - 09/30/25 - 6.84 06/30/25 - 6.64 Current Ratio 12/31/25 - - 09/30/25 - 1.13 06/30/25 - 1.09 Quick Ratio 12/31/25 - - 09/30/25 - 1.04 06/30/25 - 0.99 Operating Margin 12/31/25 - - 09/30/25 - 10.10 06/30/25 - 10.09 Net Margin 12/31/25 - - 09/30/25 - 8.91 06/30/25 - 9.01 Pre-Tax Margin 12/31/25 - - 09/30/25 - 11.86 06/30/25 - 11.93 Book Value 12/31/25 - - 09/30/25 - 65.58 06/30/25 - 64.97 Inventory Turnover 12/31/25 - - 09/30/25 - 38.60 06/30/25 - 37.68 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.71 06/30/25 - 0.71 Debt-to-Capital 12/31/25 - - 09/30/25 - 41.86 06/30/25 - 41.95

Powered by Zacks Investment Research ©